Am Fam Physician. 2003 Mar 15;67(6):1188.
Importance of Colorectal Cancer Screening
to the editor: I read with great interest the article “Recent Developments in Colorectal Cancer Screening and Prevention,”1 in American Family Physician. This article hit home on a personal level since my father died of colorectal cancer in 2001. The article1 provided an excellent literature update that confirmed that screening for colorectal cancer by fecal occult blood testing (FOBT), flexible sigmoidoscopy, double-contrast barium enema, or colonoscopy is cost-effective when compared with no screening. Screening with colonoscopy alone every 10 years, or with the combination of flexible sigmoidoscopy and FOBT, were the most effective strategies in terms of life-years saved.1
Further work needs to be done to improve the specificity of FOBT while preserving its sensitivity for detecting curable cancers and smaller polyps. Although the findings of one trial2 suggest that FOBT can reduce the incidence of colorectal cancer, FOBT has many limitations, including a low sensitivity for polyps, especially the smaller ones. Many screens are false positive, and the test has a low sensitivity for detecting cancers located in the proximal colon. In addition, the topography of colorectal cancer varies by race, which creates racial differences in the utility of such screening tests as flexible sigmoidoscopy and FOBT.3
Furthermore, patients have preferences for colorectal cancer screening techniques that are modestly sensitive to information about test performance and strongly sensitive to the out-of-pocket cost.4
The screening and prevention of colorectal cancer will continue to be an important issue for family physicians. It is vital that training programs for family physicians and students stress the importance of screening for colorectal cancer. Colorectal cancer screening should be offered based on national guidelines and on shared decision-making between the patient and the physician.
REFERENCESshow all references
1. Pignone M, Levin B. Recent developments in colorectal cancer screening and prevention. Am Fam Physician. 2002;66:297–302....
2. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343:1603–7.
3. Theuer CP, Taylor TH, Brewster WR, Campbell BS, Becerra JC, Anton-Culver H. The topography of colorectal cancer varies by race/ethnicity and affects the utility of flexible sigmoidoscopy. Am Surg. 2001; Dec;67:1157–61.
4. Pignone M, Bucholtz D, Harris R. Patient preferences for colon cancer screening. J Gen Intern Med. 1999;14:432–7.
Send letters to email@example.com, or 11400 Tomahawk Creek Pkwy., Leawood, KS 66211-2680. Include your complete address, e-mail address, and telephone number. Letters should be fewer than 400 words and limited to six references, one table or figure, and three authors.
Letters submitted for publication in AFP must not be submitted to any other publication. Possible conflicts of interest must be disclosed at time of submission. Submission of a letter will be construed as granting the AAFP permission to publish the letter in any of its publications in any form. The editors may edit letters to meet style and space requirements.
This series is coordinated by Kenny Lin, MD, MPH, Associate Deputy Editor for AFP Online.
Copyright © 2003 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact firstname.lastname@example.org for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions